摘要
结直肠癌是世界范围内最常见的癌症之一,在西方社会其发病率排在肿瘤的第2位,其肝转移是影响结直肠癌预后的重要因素,也是最常见的转移性肝癌.手术是目前唯一有效的治愈手段,5年存活率超过50%,但仅有10%-20%结直肠癌肝转移患者确诊时适合于手术切除,因此各种非手术治疗的作用正日益受到关注.随着科学技术的发展,125I粒子永久性组织间植入内放射已成为结直肠癌肝转移治疗的新热点,本文拟就其在结直肠癌肝转移方面的治疗进展作一简要综述.
Colorectal cancer is one of the most common cancers worldwide and the second most common type of cancer in the Western world. Colorectal cancer is the most common source of metastatic liver cancer,and liver metastasis is an important prognostic factor for colorectal cancer.Hepatic resection is the treatment of choice for colorectal liver metastases.The postoperative 5-year survival rate for patients with colorectal liver metastase now exceeds 50%.However,hepatic resection is indicated for only 10%-25%of patients with colorectal liver metastases.Therefore,non-surgical methods have attracted increasing attention.Permanent ^125I seed implantation is now becoming a hotspot for treatment of colorectal liver metastases.This review will focus on the recent advances in permanent ^125I seed implantation for colorectalliver metastases.
出处
《世界华人消化杂志》
CAS
北大核心
2009年第32期3324-3327,共4页
World Chinese Journal of Digestology
基金
云南省科技计划项目联合专项基金资助项目
No.2007C0039R
云南省昆明医学院硕士研究生创新基金资助项目
No.KM2008L04~~
